|
注册号: Registration number: |
ChiCTR2300074563 |
|
最近更新日期: Date of Last Refreshed on: |
2023-12-17 15:23:44 |
|
注册时间: Date of Registration: |
2023-08-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于重症超声方案构建全中国不同海拔地区健康新生儿超声指标参考值范围 |
|
Public title: |
Based on the intensive ultrasound scheme, the reference value range of ultrasound index of healthy newborns in different altitudes in China was constructed. |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于重症超声方案构建全中国不同海拔地区健康新生儿超声指标参考值范围 |
|
Scientific title: |
Based on the intensive ultrasound scheme, the reference value range of ultrasound index of healthy newborns in different altitudes in China was constructed. |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
全雄杰 |
研究负责人: |
巨容 |
|
Applicant: |
Quan Xiongjie |
Study leader: |
Ju Rong |
|
申请注册联系人电话: Applicant telephone: |
+86 136 4898 9414 |
研究负责人电话:
Study leader's |
+86 28 6186 6039 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
jiehua777@hotmail.com |
研究负责人电子邮件: Study leader's E-mail: |
jiehua777@hotmail.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
西藏拉萨市城关区林廓北路14号 |
研究负责人通讯地址: |
四川省成都市青羊区日月大道1617号 |
|
Applicant address: |
14 Linkuo North Road, Chengguan District, Lhasa, Tibet |
Study leader's address: |
1617 Riyue Avenue, Qingyang District, Chengdu, Sichuan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
西藏阜康医疗股份有限公司 |
||
|
Applicant's institution: |
Tibet Fukang Medical Co., Ltd |
||
|
研究负责人所在单位: |
成都市妇女儿童中心医院 |
||
|
Affiliation of the Leader: |
Chengdu Women's and Children's Center Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
科研伦理预审2022(104) |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
成都市妇女儿童中心医院伦理审查委员会 |
||
|
Name of the ethic committee: |
Ethics Review Committee of Chengdu Women's and Children's Center Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-09-27 00:00:00 | ||
|
伦理委员会联系人: |
干晓琴 |
||
|
Contact Name of the ethic committee: |
Gan Xiao Qin |
||
|
伦理委员会联系地址: |
四川省成都市青羊区日月大道1617号 |
||
|
Contact Address of the ethic committee: |
1617 Riyue Avenue, Qingyang District, Chengdu, Sichuan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 28 6186 6009 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
成都市妇女儿童中心医院 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Chengdu women and children's center hospital |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
四川省成都市青羊区日月大道1617号 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
1617 Riyue Avenue, Qingyang District, Chengdu, Sichuan |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
西藏阜康医疗股份有限公司 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Tibet Fukang Medical Co.Ltd |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
不同海拔地区新生儿重症超声正常参考值 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Normal reference values for neonatal intensive ultrasound at different altitudes |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
1.基于重症超声方案,测量不同海拔地区健康新生儿肺部超声相关参数、大脑血流动力和基础心功能参数,构建心、肺、脑一体化超声数据库; 2.根据上述数据库,绘制心、肺、脑相关测量值的参数值图谱; 3.通过该数据库及参考值图谱,构建识别危重新生儿的智能诊疗系统。 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
1.Based on the severe ultrasound protocol, measure the lung ultrasound related parameters, cerebral hemodynamics, and basic cardiac function parameters of healthy newborns at different altitudes, and construct an integrated ultrasound database of heart, lung, and brain; 2.Based on the above database, draw a parameter map of heart, lung, and brain related measurement values; 3.Build an intelligent diagnosis and treatment system for identifying critically ill newborns through this database and reference value graph. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.法定监护人不同意参与本研究; 2.入院后24小时内即出院者; 3.因为其他原因不能在日龄24小时内入组者; 4.合并有其他严重先天性疾病(如:复杂先天性心脏病、基因染色体病、先天性脑发育异常等)。 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. The legal guardian does not agree to participate in this study; 2. Those who are discharged within 24 hours after admission; 3. Those who cannot be enrolled within 24 hours of age due to other reasons; 4. Concomitant with other serious congenital diseases (such as complex congenital heart disease, genetic chromosomal disease, congenital brain developmental abnormalities, etc.). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-09-01 00:00:00至 To 2025-09-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-09-01 00:00:00 至 To 2025-09-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
not available |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |